Tellgen Corporation

Tellgen Corporation was established in 2003, specializing in the research and development, production, promotion, and sales of high-end in vitro diagnostic products. The application of Tellgen products covers cancer prognosis, cardiovascular disease, autoimmune disease, pathogen infection, reproductive health, using multiplexed bead flow fluorescence, chemiluminescence, fluorescence PCR, and liquid chromatography with tandem mass spectrometry (LC-MS-MS).